These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3402527)

  • 1. Pharmacokinetics and pharmacodynamics of single oral doses of ibopamine, quinidine and their combination in normal man.
    de Mey C; Enterling D; Brendel E; Wesche H
    Eur J Clin Pharmacol; 1988; 34(4):415-8. PubMed ID: 3402527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of ibopamine on different diseases and conditions.
    Ventresca GP; Lodola E
    Arzneimittelforschung; 1988 Aug; 38(8):1175-80. PubMed ID: 2904270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibopamine kinetics after single and multiple dosing in patients with congestive heart failure.
    Azzollini F; De Caro L; Longo A; Pelosi G; Rolandi E; Ventresca GP; Lodola E
    Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):544-51. PubMed ID: 3243658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oral dopamine agonist, ibopamine, in normal man: effects on rhythm, heart rate, blood pressure and catecholamines.
    Van Veldhuisen DJ; Girbes AR; Crijns HJ; Smit AJ; Van Gilst WH; Lie KI
    Int J Clin Pharmacol Res; 1991; 11(3):159-65. PubMed ID: 1687321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibopamine (SK&F 100168) pharmacokinetics in relation to the timing of meals.
    Scott SC; Locke-Haydon J; Pready NS; Buller NP; Cregeen RJ
    Br J Clin Pharmacol; 1987 May; 23(5):585-7. PubMed ID: 3593628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the bioequivalence of three oral formulations of ibopamine in healthy volunteers.
    Douchamps J; Juvent M; Vanschoubroek K; Seth A; Deger F; Derenne F; Herchuelz A
    Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):482-6. PubMed ID: 3069751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of a possible pharmacokinetic interaction between ibopamine and isosorbide-5-mononitrate.
    Lefebvre RA; De Wilde G; Rosseel MT; Duprez D; De Sutter J; Pocchiari F
    Eur J Clin Pharmacol; 1992; 42(5):549-52. PubMed ID: 1607003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibopamine kinetics after a single oral dose in patients with congestive heart failure.
    Azzollini F; Cattò G; Iacuitti G; Pelosi G; Picca M; Pocchiari F; Pataccini R; Castelnovo P; Longo A; Ventresca GP
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):105-12. PubMed ID: 3410586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
    Di Mario C; Compostella L; Iavernaro A; Libardoni M; Ghirardi P; Cucchini F
    Arzneimittelforschung; 1990 Jun; 40(6):661-6. PubMed ID: 2397001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L; Metra M; Nodari S; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic interactions between single oral doses of ibopamine and food in normal man.
    de Mey C; Enterling D; Meineke I
    Arzneimittelforschung; 1989 Sep; 39(9):1138-43. PubMed ID: 2590265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dopamine, ibopamine, and epinine on alpha- and beta-adrenoceptors in canine pulmonary circulation.
    Shebuski RJ; Smith JM; Ruffolo R
    Fundam Clin Pharmacol; 1989; 3(3):211-21. PubMed ID: 2548941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
    Henwood JM; Todd PA
    Drugs; 1988 Jul; 36(1):11-31. PubMed ID: 3063492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine.
    Metra M; Missale C; Spano PF; Cas LD
    J Cardiovasc Pharmacol; 1995 May; 25(5):732-40. PubMed ID: 7630152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute haemodynamic effects of ibopamine and dopamine on isovolumic relaxation.
    Bernardi L; Perlini S; Soffiantino F; Farilla C; Calciati A; Soldá PL; Paro M; Merlo L; Marchetti G; Finardi G
    Eur J Pharmacol; 1989 May; 164(3):415-24. PubMed ID: 2767116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in rats.
    Pocchiari F; Pataccini R; Castelnovo P; Longo A; Casagrande C
    Arzneimittelforschung; 1986 Feb; 36(2A):334-40. PubMed ID: 3707645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the alpha and beta adrenoceptor-mediated activities of the novel, orally active inotropic agent, ibopamine, in the cardiovascular system of the pithed rat: comparison with epinine and dopamine.
    Nichols AJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):455-63. PubMed ID: 3039117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
    De Vita C; Triulzi E; Devizzi S; Colombo G; Palvarini M; Pocchiari F; Pataccini R
    Arzneimittelforschung; 1986 Feb; 36(2A):349-54. PubMed ID: 3707648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
    Kopia GA; Ohlstein EH; Ruffolo RR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):434-40. PubMed ID: 3404441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.